GeneralConnection.com ➔ Dictionary
Dictionary Search

apogee

Synonyms

Noun

1. culmination

2. phase, stage, apoapsis

3. point of apoapsis

Usage
Apogee Taps Familiar Face to Lead Architectural Glass Division - USGlass Magazine
Here's Why Apogee Enterprises (APOG) Could be Great Choice for a Bottom Fisher - Yahoo Finance
AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs - BioPharma Dive
AbbVie inks $10.9B Apogee buyout to bag hotly tipped eczema prospect - Fierce Biotech
Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilot - Endpoints News
Do Options Traders Know Something About Apogee Stock We Don't? - TradingView
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion - WSJ
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push - CNBC
AbbVie sharpens immunology focus with $10.9 billion Apogee deal - Reuters
Business Watch: Evonik to cut 3,200 jobs; AbbVie buys Apogee for almost $11 billion - Chemical & Engineering News
AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal - Pharmaceutical Executive
AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics - Financial Times
Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is Rising - Barron's
Apogee (NASDAQ:APOG) Delivers Impressive Q2 CY2026, Stock Soars - StockStory
Apogee Architectural Metals Expands EFCO, Tubelite and Wausau Representation - USGlass Magazine
AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports - Reuters
Enterprise value to EBIT forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
AbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug - Financial Times
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger - Yahoo Finance
Apogee Q1 Earnings Beat Estimates on Pricing, Productivity Gains - Yahoo Finance
AbbVie said to be nearing a $10.9B deal to buy Apogee Therapeutics - MSN
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion - Paul, Weiss
Why Apogee Enterprises Stock Is Skyrocketing Today - Yahoo Finance
AbbVie to buy Apogee Therapeutics in nearly $11B deal - STAT
AbbVie deepens immunology legacy in $10.9bn Apogee buyout - Pharmaceutical Technology
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal - 24/7 Wall St.
AbbVie to Acquire Apogee Therapeutics for $10.9B - Genetic Engineering and Biotechnology News
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal - Yahoo Finance
AbbVie Acquires Apogee, FDA Changes Tune on RegenxBio, & Merck Seizes TL1A Lead - Timmerman Report
Apogee Enterprises (APOG) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
AbbVie-Apogee acquisition a ‘solid fit,’ JPMorgan says - Investing.com
Why Apogee Enterprises (APOG) Is Up 18.5% After Earnings Turnaround And 2027 Outlook Reaffirmation - Yahoo Finance
AbbVie (ABBV) to Acquire Apogee Therapeutics - Yahoo Finance
AbbVie acquires Apogee Therapeutics for $10.9 billion - Yahoo Finance
Artemis II Flight Update: Apogee Raise Burn Complete, Crew Looks Ahead to Proximity Operations - NASA (.gov)
Apogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3 - Fierce Biotech
Apogee eczema drugs gets Blackstone backing, heads to Phase 3 - BioPharma Dive
Certified Enameling to Represent Apogee Architectural Metals in Southern California, Southern Nevada, Hawaii - Glass Magazine - NGA
Apogee Enterprises (APOG) Makes a $115 Million Bet; Could This Acquisition Reshape Its Growth Story? - Yahoo Finance
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion, Gaining IL-13 Antibody Zumilokibart - BioPharm International
AbbVie Goes On The Offensive With $10.9 Billion Takeover - Investor's Business Daily
Apogee (APOG) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Apogee Enterprises Completes Acquisition of Kalwall Companies - glassonweb.com
Summit course at Apogee: Three for three - Golf Course Architecture
AbbVie To Buy Apogee Therapeutics For $10.9 Billion - Pulse 2.0
Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss - BioSpace
Apogee secures up to $1.3 billion from Blackstone to advance eczema drug - Reuters
AbbVie: Apogee Deal Just Widened An Already Dominant Moat - Seeking Alpha
Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis - GlobeNewswire
AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors. - Yahoo Finance
Is AbbVie a Buy After Its Purchase of Apogee? - The Motley Fool
Blackstone Injecting Up to $1.3 Billion in Apogee for Skin Drug - Bloomberg.com
AbbVie’s biggest deal since 2019 could land soon - thestreet.com
AbbVie to buy immunology drugmaker Apogee for $10.9 billion - MSN
Inside the Villas at One of the Most Exclusive Golf Clubs in the Country - ELLE Decor
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - Yahoo Finance
Apogee strengthens case for longer-lasting eczema drug - BioPharma Dive
AbbVie Sharpens Immunology Focus With $10.9 Billion Apogee Deal - U.S. News & World Report
Latham Advises Apogee Therapeutics in Strategic Financing Collaboration - Latham & Watkins LLP
AbbVie said to be nearing a $10.9B deal to buy Apogee Therapeutics - Seeking Alpha
Why Apogee Enterprises Stock Is Skyrocketing Today - The Motley Fool
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - 24/7 Wall St.
Apogee Therapeutics (APGE) Proxy filing Summary - Quartr
Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear - Fierce Biotech
Apogee’s Zumilokibart Advances Toward Phase 3 After Positive Phase 2 Atopic Dermatitis Results - BioPharm International
APOGEE ENTERPRISES ($APOG) Releases Q1 2027 Earnings - Quiver Quantitative
Apogee Enterprises: Hedge Against AI Portfolio Risk - Seeking Alpha
Apogee Therapeutics Shares Surge Following $1.3 Billion Blackstone Financing Partnership (APOG) - Yahoo Finance
Stocks making the biggest moves premarket: Apogee Therapeutics, SpaceX, Arcosa & more - CNBC
Apogee (APOG) Q1 2027 Earnings Call Transcript - The Motley Fool
AbbVie seals $10.9 billion deal to acquire biotech Apogee Therapeutics - The Business Journals
Apogee Enterprises (APOG) Could Be 15% Overvalued On Its Diversified Growth Narrative - simplywall.st
Apogee’s Royalty Deal With Blackstone Will Fund Pivotal Test in Eczema and More - MedCity News
Shareholder Alert: Ademi LLP investigates whether Apogee - GlobeNewswire
AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers - Yahoo Finance
Alluring Apogee – Unfolding Without Drifting Away - Metal Temple Magazine
PR News | Joele Frank Handles Apogee’s $11B Deal - Mon., Jun. 22, 2026 - O'Dwyer's PR
BRIEF—AbbVie said to be buying Apogee - The Pharma Letter
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart - Yahoo Finance
Apogee Therapeutics Soars After $1.3B Deal with Blackstone Life Sciences - StockInvest.us
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash - Bloomberg.com
Apogee Therapeutics Announces Positive 16-Week Part B - GlobeNewswire
Colorado Springs cybersecurity firm moves into new building, wins major GPS contract - Colorado Springs Gazette
Apogee Enterprises: Fiscal Q1 Earnings Snapshot - kare11.com
Apogee Therapeutics data show long-acting eczema drug induced relief with less frequent injections - STAT
AbbVie to acquire Apogee Therapeutics in $10.9bn deal - PMLiVE
Assessing Apogee Therapeutics (APGE) Valuation After Positive Phase 2 APEX Results For Zumilokibart - Yahoo Finance
Apogee Enterprises: Fiscal Q1 Earnings Snapshot - KTVB
Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results - GlobeNewswire
AbbVie makes $10.9B move for Apogee’s long-acting I&I drug candidates - Endpoints News
APOGEE ENTERPRISES, INC. 1Q FY2027: Revenue $342.7M, EPS $0.54— 10-Q Summary - TradingView
Apogee: "Hold" On AbbVie $10.9B Buyout And Extended Half-Life IL-13 Zumilokibart For AD - Seeking Alpha
Watch AbbVie to Buy Apogee Therapeutics for $10.9 Billion - Bloomberg.com
Apogee’s Zumilokibart Hits 65.9% EASI-75 Response in Phase 2 AD Trial - The Clinical Trial Vanguard
AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion - Yahoo Finance
Apogee Enterprises (APOG) Stock Faces Margin Hit As 3.9% Net Profit Challenges Bullish Narratives - simplywall.st
Apogee Awarded $103.6M to Support DoD Positioning, Navigation, and Timing Modernization - Inside GNSS
AbbVie strikes $10.9 billion deal for Apogee Therapeutics - Yahoo Finance
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - Yahoo Finance
Apogee Exhibits planning move from Macedon to new home - Rochester Business Journal
Foreign Language Equivalents
Foreign Language Equivalents of 'apogee'
Language Equivalent   Language Equivalent
French apogée    Spanish
Misspellings - Typos
apogeee,   apogew,   aoogee,   pogee,   apoger,   apigee,   apogre,   apogeee,   apohee,   apofee,   paogee,   apoege,   apoee,   a[ogee,   apoge,   appogee,   apogwe,   aogee,   spogee,   apoogee,   apoge,   apgoee,   aopgee,   apgee,   apoggee,   aapogee,   appgee
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z